Skip to main content
For COVID-19 vaccine updates, please review
our information guide
. For patient eligibility and scheduling availability, please visit
VaccineTogetherNY.org
.
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Joint Clinical Trials Office
Explore this Website
Home
About
Toggle About menu options
News
JCTO Contacts
Careers
Our Clinical Trial Locations
Partner with the JCTO
Toggle Partner with the JCTO menu options
JCTO Fees
Open Clinical Trials
Investigators
Patients
Toggle Patients menu options
What is a Clinical Trial?
Frequently Asked Questions
Clinical Trial Questions to Ask Your Healthcare Team
Clinical Trials: Common Terms to Know
Understanding Clinical Trials and How They Work
Understanding Clinical Trials - In Spanish | En Español
Weill Cornell Medicine
Care
Discover
Teach
Home
About
Open Clinical Trials
Investigators
Patients
Home
Clinical Trials
An Adaptive, Open-Label, Dose-Finding, Phase 1/2 Study Investigating the Safety, Pharmacokinetics, and Clinical Activity of PRN1008, an Oral BTK Inhibitor, in Patients with Relapsed Immune Thrombocytopenic Purpura
Study Status:
Open to Enrollment
Primary Investigator:
Date:
April 25, 2019
Brain Function, Emotions, and Behavior in Healthy Older Adults
Study Status:
Open to Enrollment
Primary Investigator:
Date:
July 16, 2019
Positive Valence System Function and Reward Exposure Therapy for Late-Life Depression
Study Status:
Open to Enrollment
Primary Investigator:
Date:
July 16, 2019
Efficacy of Biomarker-Guided rTMS for Treatment Resistant Depression
Study Status:
Open to Enrollment
Primary Investigator:
Date:
July 16, 2019
A POC Clinical Trial for a First-in-Class Vasopressin 1a Receptor Antagonist
Study Status:
Open to Enrollment
Primary Investigator:
Date:
July 19, 2019
A Non-Inferiority Randomized Controlled Clinical Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Consequent to Military Sexual Trauma (MST) in Male and Female Military Personnel and Veterans
Study Status:
Open to Enrollment
Primary Investigator:
Date:
July 19, 2019
A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients with Chronic Lymphocytic Leukemia (CLL)
Study Status:
Open to Enrollment
Primary Investigator:
Date:
August 6, 2019
Assessment of Physiological Reactions Associated with Post-traumatic Stress Disorder Due to Military Sexual Trauma in Female Service Members
Study Status:
Open to Enrollment
Primary Investigator:
Date:
August 9, 2019
Problem Adaptation Therapy for Mild Cognitive Impairment and Depression
Study Status:
Open to Enrollment
Primary Investigator:
Date:
August 9, 2019
Relief: A Behavioral Intervention for Depression and Chronic Pain in Primary Care
Study Status:
Open to Enrollment
Primary Investigator:
Date:
October 3, 2019
1
(current)
2
3
4
5
6
7
8
9
…
next ›
last »